VBI Vaccines Profitability Analysis
VBIV Stock | USD 0.60 0.03 4.76% |
Net Loss | First Reported 1998-03-31 | Previous Quarter -13 K | Current Value -13 K | Quarterly Volatility 12 M |
For VBI Vaccines profitability analysis, we use financial ratios and fundamental drivers that measure the ability of VBI Vaccines to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well VBI Vaccines utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between VBI Vaccines's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of VBI Vaccines over time as well as its relative position and ranking within its peers.
VBI |
Is VBI Vaccines' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VBI Vaccines. If investors know VBI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VBI Vaccines listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.03) | Revenue Per Share 0.558 | Quarterly Revenue Growth 1.911 | Return On Assets (0.29) | Return On Equity (2.59) |
The market value of VBI Vaccines is measured differently than its book value, which is the value of VBI that is recorded on the company's balance sheet. Investors also form their own opinion of VBI Vaccines' value that differs from its market value or its book value, called intrinsic value, which is VBI Vaccines' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VBI Vaccines' market value can be influenced by many factors that don't directly affect VBI Vaccines' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VBI Vaccines' value and its price as these two are different measures arrived at by different means. Investors typically determine if VBI Vaccines is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VBI Vaccines' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
VBI Vaccines Return On Asset vs. Return On Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining VBI Vaccines's current stock value. Our valuation model uses many indicators to compare VBI Vaccines value to that of its competitors to determine the firm's financial worth. VBI Vaccines is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . At this time, VBI Vaccines' Return On Equity is fairly stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value VBI Vaccines by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for VBI Vaccines' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the VBI Vaccines' earnings, one of the primary drivers of an investment's value.VBI Return On Asset vs. Return On Equity
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
VBI Vaccines |
| = | -2.59 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
VBI Vaccines |
| = | -0.29 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
VBI Return On Asset Comparison
VBI Vaccines is currently under evaluation in return on asset category among related companies.
VBI Vaccines Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in VBI Vaccines, profitability is also one of the essential criteria for including it into their portfolios because, without profit, VBI Vaccines will eventually generate negative long term returns. The profitability progress is the general direction of VBI Vaccines' change in net profit over the period of time. It can combine multiple indicators of VBI Vaccines, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last Reported | Projected for Next Year | ||
Accumulated Other Comprehensive Income | 28.3 M | 29.7 M | |
Operating Income | -55.3 M | -52.5 M | |
Income Before Tax | -92.8 M | -88.2 M | |
Total Other Income Expense Net | -37.5 M | -35.6 M | |
Net Loss | -92.8 M | -88.2 M | |
Income Tax Expense | 31.8 M | 33.4 M | |
Net Loss | -114 M | -108.3 M | |
Net Loss | -102 M | -96.9 M | |
Interest Income | 2 M | 2.1 M | |
Net Interest Income | -5.9 M | -5.6 M | |
Non Operating Income Net Other | -24.7 M | -23.5 M | |
Change To Netincome | 44.3 M | 46.5 M | |
Net Loss | (5.96) | (6.26) | |
Income Quality | 0.66 | 0.99 | |
Net Income Per E B T | 1.43 | 1.44 |
VBI Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on VBI Vaccines. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of VBI Vaccines position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the VBI Vaccines' important profitability drivers and their relationship over time.
VBI Vaccines Profitability Trends
VBI Vaccines profitability trend refers to the progression of profit or loss within a business. An upward trend means that VBI Vaccines' profit has generally increased over time, and a downward profitability trend means profits are declining. Recognizing problems early in profitability trends allows investors to address revenue and cost issues in advance. Investors and analysts usually monitor three types of profitability trends: gross, operating, and net. Gross profit is the difference between revenue and costs of goods sold. Operating profit is VBI Vaccines' gross profit minus its overhead. After you account for other unusual revenue, expenses, and costs, you get net profit. Gross profit trends are often a good indicator of future profitability. If you have high gross profit margins, you have a better chance to cover overhead and make money.
VBI Vaccines Profitability Drivers Correlations
One of the toughest challenges investors face today is learning how to quickly synthesize and read into endless financial statements and information provided by the company, SEC reporting, and various external parties. Understanding the correlation between VBI Vaccines different financial indicators related to revenue and profit generation helps investors identify and prioritize their investing strategies towards VBI Vaccines in a much-optimized way. Analyzing correlations between profit drivers that are directly associated with dollar figures is the most effective way to break down VBI Vaccines' future profitability.
Click cells to compare fundamentals
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in VBI Vaccines without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
All Next | Launch Module |
Use Investing Themes to Complement your VBI Vaccines position
In addition to having VBI Vaccines in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Obamacare Thematic Idea Now
Obamacare
Health care services and providers including hospitals, clinics and nursing homes that hope to benefit from Obamacare program. The Obamacare theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Obamacare Theme or any other thematic opportunities.
View All Next | Launch |
Check out World Market Map. For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for VBI Stock analysis
When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
To fully project VBI Vaccines' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of VBI Vaccines at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include VBI Vaccines' income statement, its balance sheet, and the statement of cash flows.